首页> 美国卫生研究院文献>British Journal of Clinical Pharmacology >Comparison of pharmacokinetic profiles of single and multiple doses of a slow release Oros oxprenolol delivery system in young normotensive and elderly hypertensive subjects.
【2h】

Comparison of pharmacokinetic profiles of single and multiple doses of a slow release Oros oxprenolol delivery system in young normotensive and elderly hypertensive subjects.

机译:单次和多次剂量的Oros oxprenolol缓释系统在年轻的正常血压和老年高血压受试者中的药代动力学特征比较。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Oxprenolol in an Oros 8/130 sustained release osmotic pump system (equivalent to 120 mg oxprenolol hydrochloride in a conventional formulation and releasing 8 mg h-1) was given to eight normal young subjects (mean age 23 years) and eight elderly hypertensive patients (mean age 77 years). The plasma concentration-time profiles of oxprenolol were determined over 32 h using gas liquid chromatography after the initial dose and following seven doses. The elderly patients had a significantly higher AUC and maximum plasma oxprenolol concentration following both the first and final doses studied. It is unlikely that this difference is due to a prolonged absorption phase in the elderly patients. Reduced drug clearance seems the most probable explanation.
机译:向八名正常年轻受试者(平均年龄23岁)和八名老年高血压患者服用Oros 8/130缓释渗透泵系统(相当于传统制剂中的120毫克盐酸盐酸戊丙诺尔,并释放8毫克h-1)中的奥曲洛诺。平均年龄77岁)。在初始剂量后和七次剂量后,使用气相色谱法在32小时内测定了oxprenolol的血浆浓度-时间曲线。在研究的第一剂和最终剂之后,老年患者的AUC和最大血浆奥昔洛尔浓度均显着较高。这种差异不太可能是由于老年患者吸收期延长所致。药物清除率降低似乎是最可能的解释。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号